Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region

[1]  N. Bornfeld,et al.  Current Concepts for Diagnosis and Treatment of Retinoblastoma in Germany: Aiming for Safe Tumor Control and Vision Preservation , 2012, Klinische Pädiatrie.

[2]  R. M. Singa,et al.  Evisceration and enucleation: a national survey of practice patterns in the United States. , 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[3]  S. Brodie,et al.  Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results , 2012, British Journal of Ophthalmology.

[4]  I. B. Buttanri,et al.  Long-Term Outcomes of Pegged and Unpegged Bioceramic Orbital Implants , 2012, Ophthalmic plastic and reconstructive surgery.

[5]  C. Shields,et al.  Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned? , 2012, Current opinion in ophthalmology.

[6]  L. Phan,et al.  Evisceration in the Modern Age , 2012, Middle East African journal of ophthalmology.

[7]  Sanket U. Shah,et al.  Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. , 2012, Ophthalmology.

[8]  M. Connor,et al.  Re: "comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients". , 2011, Ophthalmic plastic and reconstructive surgery.

[9]  R. Halli,et al.  Modified lateral orbitotomy approach: a novel technique in the management of lacrimal gland tumors. , 2011, The Journal of craniofacial surgery.

[10]  H. Eftekhar,et al.  Comparison of the Exposure Rate of Wrapped Hydroxyapatite (Bio-Eye) Versus Unwrapped Porous Polyethylene (Medpor) Orbital Implants in Enucleated Patients , 2011, Ophthalmic plastic and reconstructive surgery.

[11]  C. Rodríguez-Galindo,et al.  Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators , 2010, British Journal of Ophthalmology.

[12]  S. Brodie,et al.  Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). , 2010, Ophthalmology.

[13]  A. Pesqueira,et al.  Orbital Implants Insertion to Improve Ocular Prostheses Motility , 2010, The Journal of craniofacial surgery.

[14]  C. Shields,et al.  Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy , 2010, Current opinion in ophthalmology.

[15]  Matthew W. Wilson,et al.  Enucleation for retinoblastoma: the experience of a single center in Jordan , 2010, International Ophthalmology.

[16]  D. Belen,et al.  Lateral orbitotomy approach to orbital tumors: report of 10 cases. , 2010, Turkish neurosurgery.

[17]  N. Rao,et al.  Changing causes of enucleation over the past 60 years , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  R. Goldberg,et al.  Total Lateral Orbitotomy , 2009, Orbit.

[19]  R. Pelton.  The anterior eyelid crease approach to the orbit , 2009, Current opinion in ophthalmology.

[20]  C. Shields,et al.  Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. , 2009, Ophthalmology.

[21]  S. Liao,et al.  Late exposure of the bioceramic orbital implant. , 2009, American journal of ophthalmology.

[22]  M. Samaila.  Malignant tumours of childhood in Zaria. , 2009, African journal of paediatric surgery : AJPS.

[23]  J. Jonas,et al.  Review of 1375 enucleations in the TongRen Eye Centre, Beijing , 2008, Eye.

[24]  D. Weinberger,et al.  [Enucleations and eviscerations in a large medical center between the years 1981 and 2007]. , 2008, Harefuah.

[25]  C. Hintschich,et al.  Primary Dermis-Fat Grafting in Children , 2008, Orbit.

[26]  M. Sagoo,et al.  UK national survey of enucleation, evisceration and orbital implant trends , 2006, British Journal of Ophthalmology.

[27]  B. Yazıcı,et al.  Complications of primary placement of motility post in porous polyethylene implants during enucleation. , 2007, American journal of ophthalmology.

[28]  K. Trinkaus,et al.  Porous Implant Exposure: Incidence, Management, and Morbidity , 2007, Ophthalmic plastic and reconstructive surgery.

[29]  A. Nemet,et al.  The Lateral Triangle Flap—A New Approach for Lateral Orbitotomy , 2007, Orbit.

[30]  A. Shoamanesh,et al.  Complications of Orbital Implants: A Review of 542 Patients Who Have Undergone Orbital Implantation and 275 Subsequent Peg Placements , 2007, Orbit.

[31]  V. Esposito,et al.  Surgical exposure of lateral orbital lesions using a coronal scalp flap and lateral orbitozygomatic approach: clinical experience , 2006, Acta Neurochirurgica.

[32]  P. Novaes,et al.  Treatment of Retinoblastoma Patients With Chemoreduction Plus Local Therapy: Experience of the AC Camargo Hospital, Brazil , 2006, Journal of pediatric hematology/oncology.

[33]  E. Gönül,et al.  Lateral approach to the orbit: An anatomical study , 2006, Neurosurgical Review.

[34]  H. Kıratlı,et al.  Transconjunctival approach for retrobulbar intraconal orbital cavernous hemangiomas. Orbital surgeon's perspective. , 2005, Surgical neurology.

[35]  J. Augsburger,et al.  Enucleation With Unwrapped Porous and Nonporous Orbital Implants: A 15-Year Experience , 2004, Ophthalmic plastic and reconstructive surgery.

[36]  P. Pellerin,et al.  [Eyelid crease incision for lateral orbitotomy]. , 2005, Annales de chirurgie plastique et esthetique.

[37]  Z. Mariak,et al.  [Clinical indications for enucleation in the material of Department of Ophthalmology, Medical Academy in Białystok in the years 1982-2002]. , 2005, Klinika oczna.

[38]  C. Shields,et al.  CONTINUING CHALLENGES IN THE MANAGEMENT OF RETINOBLASTOMA WITH CHEMOTHERAPY , 2004, Retina.

[39]  David Chen,et al.  Management of the anophthalmic socket in pediatric patients , 2004, Current opinion in ophthalmology.

[40]  N. Taçyıldız,et al.  Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. , 2004, Ophthalmology.

[41]  Grant W Su,et al.  Current Trends in Managing the Anophthalmic Socket After Primary Enucleation and Evisceration , 2004, Ophthalmic plastic and reconstructive surgery.

[42]  C. Shields,et al.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. , 2004, Ophthalmology.

[43]  H. Grossniklaus,et al.  Analysis of 24,444 surgical specimens accessioned over 55 years in an ophthalmic pathology laboratory , 1997, International Ophthalmology.

[44]  M. Wilczyński,et al.  [Analysis of the causes of enucleations performed at the Department of Ophthalmology of the Medical University of Lódź]. , 2004, Klinika oczna.

[45]  S. Kaltreider,et al.  Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. , 2003, Ophthalmology.

[46]  C. Hintschich.  Dermis-Fett-Transplantat , 2003, Der Ophthalmologe.

[47]  C. Hintschich.  [Dermis-fat graft. Possibilities and limitations]. , 2003, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[48]  C. Shields,et al.  Postenucleation adjuvant therapy in high-risk retinoblastoma. , 2002, Archives of ophthalmology.

[49]  B. Neven,et al.  Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. , 2002, Medical and pediatric oncology.

[50]  C. Shields,et al.  Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. , 2002, American journal of ophthalmology.

[51]  C. Shields,et al.  Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. , 2002, Archives of ophthalmology.

[52]  M. Chen,et al.  Complications of motility peg placement for porous hydroxyapatite orbital implants , 2002, The British journal of ophthalmology.

[53]  C. Shields,et al.  Orbital tumors in the older adult population. , 2002, Ophthalmology.

[54]  J. Mora,et al.  Plaque radiotherapy for retinoblastoma. Long term tumor control and treatment complications in 208 tumors , 2002 .

[55]  M. O'hara,et al.  The autogenous dermis-fat orbital implant in children. , 2001, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[56]  Imhoff Sm,et al.  [Intraocular retinoblastoma: new therapeutic options]. , 2001 .

[57]  M. Duffy,et al.  Exposure Rates of Wrapped and Unwrapped Orbital Implants Following Enucleation , 2001, Ophthalmic plastic and reconstructive surgery.

[58]  S. Honavar,et al.  Enucleation in a tertiary eye care centre in India: Prevalence, current indications and clinico-pathological correlation , 2001, Eye.

[59]  P. De Potter,et al.  [Porous polyethylene (Medpor) orbital implant. Prospective study of 75 primary implantations]. , 2001, Journal francais d'ophtalmologie.

[60]  S. Saw,et al.  Eye cancer incidence in Singapore , 2000, The British journal of ophthalmology.

[61]  N. Davies,et al.  Exposure of primary orbital implants in postenucleation retinoblastoma patients. , 2000, Ophthalmology.

[62]  C. Shields,et al.  Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  S. Heegaard,et al.  Review of 1028 bulbar eviscerations and enucleations. Changes in aetiology and frequency over a 20-year period. , 1999, Acta ophthalmologica Scandinavica.

[64]  L. Mawn,et al.  Complications associated with pegging hydroxyapatite orbital implants. , 1999, Ophthalmology.

[65]  M. Greenwald,et al.  Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. , 1998, Ophthalmology.

[66]  D. Hodge,et al.  Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. , 1998, American journal of ophthalmology.

[67]  C. Margo,et al.  Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. , 1998, Ophthalmology.

[68]  M. Özkan,et al.  Causes of Enucleation: A Clinicopathological Study , 1997, European journal of ophthalmology.

[69]  H. Arai,et al.  Lateral approach to intraorbital lesions: anatomic and surgical considerations. , 1996, Neurosurgery.

[70]  C. Hintschich,et al.  [Dermal fatty tissue transplant as primary and secondary orbital implant. Complications and results]. , 1996, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[71]  C. Hintschich,et al.  Dermis-Fett-Transplantat als primäres und sekundäres Orbitaimplantat Komplikationen und Ergebnisse * , 1996, Der Ophthalmologe.

[72]  C. Hintschich,et al.  Dermis-Fett-Transplantat als autologes Orbitaimplantat , 1996 .

[73]  Y. Scat,et al.  [Epidemiological study of 1705 malignant tumors of the eye and adnexa]. , 1996, Journal francais d'ophtalmologie.

[74]  C. Hintschich,et al.  [Dermal fat transplant as autologous orbital implant]. , 1996, Klinische Monatsblatter fur Augenheilkunde.

[75]  S. Bellefqih,et al.  [Etiology of enucleations. Apropos of 3,246 cases]. , 1996, Journal francais d'ophtalmologie.

[76]  J. Pe’er,et al.  Changing indications for enucleations in Hadassah University Hospital, 1960-1989. , 1995, Ophthalmic epidemiology.

[77]  P. Lommatzsch,et al.  Klinisch-pathologische Studie an 817 Enukleationen , 1995 .

[78]  K. Gündüz,et al.  Pediatric Orbital Tumors in Turkey , 1995, Ophthalmic plastic and reconstructive surgery.

[79]  J. Ganley.  Changing indications for enucleations. , 1995, Ophthalmic epidemiology.

[80]  N. Gassler,et al.  [Clinicopathologic study of 817 enucleations]. , 1995, Klinische Monatsblatter fur Augenheilkunde.

[81]  A. Chakrabarti,et al.  Malignant orbital tumours: observation in north Bengal. , 1993, Journal of the Indian Medical Association.

[82]  F W Zonneveld,et al.  Prosthesis motility with and without intraorbital implants in the anophthalmic socket. , 1991, The British journal of ophthalmology.

[83]  A. J. Otto,et al.  Primary and secondary implants in the anophthalmic orbit. Preoperative and postoperative computed tomographic appearance. , 1991, Ophthalmology.

[84]  A. J. Otto,et al.  Primary Versus Secondary Intraorbital Implants , 1990, Ophthalmic plastic and reconstructive surgery.

[85]  T. Smit,et al.  [Is an implant always necessary after enucleation?]. , 1990, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[86]  C. Shields,et al.  Decreasing frequency of enucleation in patients with retinoblastoma. , 1989, American journal of ophthalmology.

[87]  S. Bosniak.  Avoiding Complications Following Primary Dermis‐Fat Orbital Implantation , 1985, Ophthalmic plastic and reconstructive surgery.

[88]  J. Maroon,et al.  Surgical approaches to the orbit. Indications and techniques. , 1984, Journal of neurosurgery.

[89]  R. Lisman,et al.  Dermis-fat orbital implantation: 118 cases. , 1983, Ophthalmic surgery.